Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000486598 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancers.
Int Urol Nephrol
December 2024
Medical Oncology Clinic, Ankara Bilkent City Hospital, 06100, Çankaya, Ankara, Turkey.
Purpose: Most bladder cancers are pure urothelial carcinomas, but a small portion, approximately 5-10%, have variant histology or are non-urothelial in nature. This research sought to examine the features of and treatment strategies for different types of urothelial carcinoma with variant histologies and non-urothelial bladder cancer.
Methods: The study cohort comprised individuals with non-urothelial and variant urothelial bladder cancers treated at two medical centres in Ankara, Turkey, between 2005 and 2024.
Sex Disparities in Bladder Cancer Diagnosis and Treatment.
Cancers (Basel)
December 2024
Medical Oncology Unit, Centre Antoine Lacassagne, Université Côte d'Azur, 06000 Nice, France.
Article Synopsis
- Gender differences significantly impact bladder cancer prevalence, with men at higher risk but women often diagnosed later with more advanced disease.
- Women face more challenges with treatment outcomes and experience higher rates of recurrence after certain therapies due to differing immunogenic responses.
- There is a pressing need for more research on sex and gender effects in bladder cancer to bridge gaps in treatment and improve prognoses for women.
Monopolar versus bipolar transurethral resection of bladder Tumour: post-hoc analysis of a prospective trial.
World J Urol
August 2024
S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Introduction: Previously, in a randomised trial we demonstrated bipolar transurethral resection of bladder tumor (TURBT) could achieve a higher detrusor sampling rate than monopolar TURBT. We hereby report the long-term oncological outcomes following study intervention.
Methods: This is a post-hoc analysis of a randomized phase III trial comparing monopolar and bipolar TURBT.
Primary large cell neuroendocrine carcinoma of the bladder: A case report.
World J Clin Cases
July 2024
Department of Urology, Hebei Medical University Third Hospital, Shijiazhuang 050051, Hebei Province, China.
Background: Large cell neuroendocrine carcinoma (LCNEC) of the bladder is a rare non-urothelial tumor of the bladder. The treatment of LCNEC of the bladder is different from that of urothelial carcinoma (UC); therefore, early and accurate diagnosis is particularly important. As LCNEC of the bladder is rare and its clinical symptoms and radiographic features are similar to those of urothelial tumors, the clinical diagnosis of the disease remains challenging.
View Article and Find Full Text PDF[A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].
Zhonghua Zhong Liu Za Zhi
July 2024
Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical sciences and Peking Union Medical college, Beijing 100021, China.
To evaluate the clinical value of the Paris system for reporting urinary cytology (TPS) in the diagnosis of urothelial carcinoma (UC). A total of 1 744 cytological diagnostic records (from 751 cases) were collected retrospectively. All specimens were voided urines and histopathology as the gold standard.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!